Aminothiazoles as FBPase inhibitors for diabetes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S367000, C514S369000, C514S371000, C546S114000, C548S163000, C548S185000, C548S196000

Reexamination Certificate

active

07973051

ABSTRACT:
Compounds of formula (I)as well as pharmaceutically acceptable salts and esters thereof, wherein R1to R3have the significance given in claim1and which can be used in the form of pharmaceutical compositions.

REFERENCES:
patent: 2006 00313 (2006-03-01), None
patent: 0 337 819 (1989-10-01), None
patent: WO 01/57037 (2001-08-01), None
patent: WO 03/039451 (2003-05-01), None
patent: WO 2005/103022 (2005-11-01), None
patent: WO 2007/137962 (2007-12-01), None
patent: WO 2007/137962 (2007-12-01), None
Bouillon et al. J Comb Chem. 2007; 9(6). Author Manuscript, pp. 1-13.
Ettmayer et al. “Lessons Learned from Marketed and Investigational Prodrugs.” J. Med. Chem., (2004), 47(10): 2393-2404.
Stella, Valentino. “Prodrugs as therapeutics.” Expert Opin. Ther. Patents (2004), 14(3): 277-280.
Testa, Bernard. “Prodrug research: futile or fertile?” Biochemical Pharmacology, 68 (2004): 2097-2106.
Wolff et al. Burger's Medicinal Chemistry and Drug Discovery. 5th ed. vol. 1: Principles and Practice (1995). pp. 975-977.
Arzneimittel Forschung, Drug Research, ECV, vol. 8, No. 7a, Jan. 1, 1958, pp. 448-454—XP009088824.
Imtiaz Husain, M, The Indian Journal of Pharmacy, CC, CC, vol. 38, No. 2, Mar. 1, 1976, pp. 47-49, XP008036020.
Yousef, Medicinal Chemistry Research, vol. 10, No. 6, XP008020857, 2001.
Zee-Cheung, Journal of Medicinal Chemistry, 22 (1), 28-32, XP002520027, 1978.
Hof, H.,Antimicrobial Chemotherapy 14 (1) 31-9—XP002520028, 1984.
Husain, M.I. et al; Indian Drugs, (1986) 24:1 p. 21.
About Out A.A. et al, J. Drugs. Res. Egypt (1974) 6:2 p. 123.
Holland, G.F.; J. Org. Chem. (1961) 26, p. 1662.
Howbert, J.J. et al: J. Med. Chem. (1990) 33:9 p. 2393.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aminothiazoles as FBPase inhibitors for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminothiazoles as FBPase inhibitors for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminothiazoles as FBPase inhibitors for diabetes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2637641

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.